A Day of Reckoning for Washington Insiders

If you know where to look, you can use the insider trades taking place on Capitol Hill to your advantage. Alexander Boulden shows you how... If you know where to look, you can use the insider trades taking place on Capitol Hill to your advantage. Alexander Boulden shows you how... [Energy and Capital logo] A Day of Reckoning for Washington Insiders By Alex Boulden Written Feb 17, 2022 “Having knowledge others lack is a very, very good investment strategy.” — Insider --------------------------------------------------------------- Dear Reader, Big waves are forming in Washington. There’s renewed pressure from the public and politicians on both sides of the aisle to place restrictions on lawmakers’ ability to trade individual stock. For once it feels like public opinion is shaping policy, the way democracy should work. A recent poll by the Convention of States Action found that 76% of voters believe lawmakers and their spouses have an unfair advantage in the stock market. This comes at a time when various members of Congress made opportunistic stock trades right before COVID-19 was publicly declared a pandemic in the U.S. In fact, the controversy’s now called the “2020 congressional insider trading scandal.” It’s a big deal. If you don’t already know what happened, here’s the rundown... Double Vision I still remember the confusing rhetoric coming out of Washington at the beginning of 2020. At the time, my team and I were figuring out the best way to report on the coronavirus. Was it a pandemic or just an epidemic? Was it even safe to be in the office? We were all left in the dark. On January 24, the Senate Committees on Health and Foreign Relations held a closed-door meeting with senators about the virus and the coming physical and economic impact it was going to have on the U.S. The public, however, wouldn’t know this information until March 11, when the World Health Organization (WHO) officially declared COVID-19 a global pandemic. [The #1 Stock Under $5[AlexGreenonStage]]( This Virginia stock-picking millionaire says it’s not about diversification! One single stock under $5 — that trades under a secret name — could help you build your retirement. [His details are here.]( As for our leaders in Washington? They knew what was coming all along and made sure to rebalance their portfolios to profit from the coming catastrophe and stock market correction. Not wasting a minute, Sen. Kelly Loeffler, who’s married to Chairman of the New York Stock Exchange Jeffrey Sprecher, sold millions of dollars’ worth of stock. On the same day as the coronavirus briefing, Sen. David Perdue sold more than $1 million of his holdings and bought DuPont, a leading manufacturer of personal protective equipment. Most blatant were Sen. Richard Burr’s transactions. As chair of the Senate Intelligence Committee, he had access to information only a small handful of people had. According to NPR, he attended a luncheon at the Capitol Hill Club on February 27, where he delivered this message: There’s one thing I can tell you about this: It is much more aggressive in its transmission than anything we have seen in recent history. It is probably more akin to the 1918 pandemic... Every company should be cognizant of that fact that you may have to alter your travel. You may have to look at your employees and judge whether the trip they’re making to Europe is essential or whether it can be done on video conference... There will be, I’m sure, times that communities... have a transmission rate where they say, “Let’s close schools for two weeks. Everybody stay home.” Sure would have been helpful for the U.S. public to have had that information. As for Burr, he and his wife sold more than $1 million worth of stock before the WHO’s global pandemic declaration. Federal Reserve Vice Chair Richard Clarida sold a stock fund in February 2020 and then bought back into it right before the Fed announced safety-net programs to curb the economic fallout from the pandemic. After his trades surfaced last month, he stepped down, just weeks before he was set to retire at the end of January. Eric Rosengren, president of the Boston Fed, and Robert Kaplan, president of the Dallas Fed, both resigned late last year after their stock dealings at the beginning of 2020 raised some eyebrows. The list goes on... Of course the ensuing Justice Department investigations didn’t do squat, and no one was held criminally accountable. So there’s clearly a double standard for lawmakers when they get in trouble. And this has caused an outcry not only from the American public but from other members of Congress. The Call’s Coming From Inside the House Now, Rep. Alexandria Ocasio-Cortez can be pretty polarizing, which is why her recent stance against congressional insider trading makes the issue even more cogent and brings it to the forefront of people's minds. In an interview with Yahoo Finance, she said at least 75 members of Congress held Johnson & Johnson, Pfizer, and Moderna stock the last two years, and continued: Members of Congress have access to very sensitive security clearances... We have access to very detailed, tailored briefs. Our job is to try to anticipate and legislate for what we see is coming. And we should not have the ability to both have access to that information and be able to hold and trade individual stock. Amen. This is popular opinion, and I think we can all get behind that. Other members of Congress don’t see it that way though. "Miracle Mineral" at Center of Multi-Trillion Wealth Bonanza Inside each of these spheres is a natural resource more important than oil, coal, or gas. It’s called the “Miracle Mineral.” [See how this little-known resource could give savvy investors the chance to turn $500 into $82,175 over the next few months.]( Speaker of the House Nancy Pelosi has been outspoken against any new bill that bans congressional trading, telling reporters that “we’re in a free market economy. [Lawmakers] should be able to participate in that.” And boy, have they been participating. Just look at the millions of dollars they spent on stock trades last year... [congress stock trades] After feeling the pressure, Nancy Pelosi has since come around, saying “I just don’t buy into it, but if members want to do that, I’m OK with that.” She doesn’t care at this point anyway; she’s already made her millions. But other Democrats think that's unfair and want their shot at profiting off the backs of the American people. Rep. Elaine Luria of Virginia sat down with Punchbowl News to deliver her opinion on the whole affair: I think this whole concept is bullshit. Because I think that, why would you assume that members of Congress are going to be inherently bad or corrupt? We already have the STOCK Act that requires people to report stock trades. Why would you... automatically assume that they’re going to use their position for some nefarious means or to benefit themselves? So I’m very strongly opposed to any legislation like that. That statement doesn't even dignify a response. Luckily, Reps. Abigail Spanberger and Chip Roy are working on their own bill to ban congressional trading, which will finally make it absolutely clear that lawmakers don’t have any ulterior motive when making decisions. Trading on the Inside For now, we’ll keep tracking congressional trading for our own benefit. Because if you know where to look, you can use these insider trades to your advantage. Fortunately, the internet has made congressional and corporate trades readily accessible. The only problem is sifting through the boring forms and cross-referencing them to find tradable patterns. But as Benjamin Franklin said, “An investment in knowledge always pays the best interest.” That’s why, in the coming months, I’ll be bringing you an exclusive opportunity to follow me as I comb through the thousands of insider trades posted every day from corporate insiders, large financial institutions, and politicians. I’ve found this strategy to be extremely profitable while giving me the confidence and peace of mind needed when pulling the trigger in such a volatile market. In the meantime, our senior tech analyst Keith Kohl is going all-in this year on biotech, a sector rife with opportunities from this COVID mess. But it’s nearly impossible for the average investor to know what’s going on behind the scenes at these drug companies. That’s why Keith’s partnered with top doctors and scientists in the industry who focus on the approval of all the niche drugs being tested right now. Keith has been known to tell his readers with pinpoint accuracy when the next biotech stock will take off. These trades often happen fast. He’s already banked his readers gains of 3,278% on Aquinox in one day and 668% on Amarin in less than a month! And he just released [a new play that could go even higher](. [Get the inside scoop]( on the next big biotech stock. Stay free, Alexander Boulden Editor, Energy and Capital --------------------------------------------------------------- How You Can Profit From Amazon’s New Care Program If you didn’t think Amazon could grow any bigger than it already is… think again. Amazon is already a $1.7 trillion tech giant with a stock price of over $3,200 per share… And it’s just launched a new telehealth program called Amazon Care. That’s right — Amazon now offers medical services including testing, vaccinations, treatment of illnesses and injuries, preventative care, and sexual health. This is a massive opportunity for Amazon’s stock to skyrocket even HIGHER. But I’m not telling you to invest in Amazon — at least not directly. I’m here to tell you there’s actually a way to piggyback off of Amazon’s sales! All you need to do is enroll in its Prime Profits payouts. You see, Amazon is required to pay tens of billions of dollars to certain companies… And the more Amazon grows, the more money it’ll be required to pay. So if you know which companies to buy, you could end up collecting a MASSIVE windfall! But I urge you to act fast, because while life-changing gains from “Prime Profits” are on the table right now… they won’t be for long. [Get the details on how you can receive these monthly payments.]( Browse Our Archives [The Dirty Truth Behind $100 Oil]( [Crypto Ad Boom Pushes Tokens Higher]( [The Tech That Will Create OR Destroy $8 Trillion Overnight]( [I Love Wall Street Carnage — New Trading System Beats Any Market]( [Is Rumble (NASDAQ: CFVI) a Good Investment?]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here]( and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Energy and Capital, Copyright © 2022, Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.](